COMPARATIVE STUDY BETWEEN 2 TYPES OF PROLOTHERAPY IN TREATMENT OF CHRONIC RECURRENT TEMPOROMANDIBULAR JOINT DISLOCATION

Document Type : Original Article

Authors

1 B.D.S, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt.

2 -Professor of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt

3 -Professor of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt.

Abstract

INTRODUCTION: Temporomandibular Joint (TMJ) dislocation when condyles travel anterior to articular eminence. It may be reducible or irreducible. Chronic recurrent TMJ dislocation was treated by surgical and nonsurgical methods. Minimally invasive methods include injection of sclerosing agents intra-articular and extra-capsular or botulinum toxin to the surrounding muscles. Prolotherapy is a method of strengthening lax ligaments by injecting various types of sclerosing or proliferant solutions such as ethanolamine oleate 5%, autologus blood and others. It is also known as "ligament sclerotherapy" or "regenerative injection therapy" OBJECTIVES: the study aimed to compare 2 types of prolotherapy (autologous blood & ethanolamine Oleate sclerosing agent) injection in treatment of chronic recurrent temporomandibular joint dislocation. MATERIALS AND METHODS: : this study was parallel, controlled, randomized, clinical trial. The study was conducted at Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt. Thirty patients with chronic recurrent temporomandibular joint dislocation were chosen with certain inclusion and exclusion criteria. Fifteen participants were injected with ethanolamine oleate compared with fifteen patients were injected with autologous blood and were followed-up for six months. The participated patients were assessed at the pre- and post-treatment stages by evaluating pain and mandibular range of motion clinically and radiographically using Magnatic Resonance Imaging (MRI) to evaluate condyle-articular eminence relation in opening and closing mouth. RESULTS: There was no significant difference between both prolotherapies in treating chronic recurrent temporomandibular joint dislocation. CONCLUSIONS: Ethanolamine oleate and autologus blood injection are simple, safe and cost-effective treatment for management of chronic recurrent temporomandibular joint dislocation

Keywords

Main Subjects

References

  1. Machon V, Abramowicz S, Paska J, Dolwick MF. Autologous blood injection for the treatment of recurrent TMJ dislocation. J Oral Maxillofac Surg. 2009;67:114-9.
  2. Çandrl C, Yüce S, Yldrm S, Sert H. Histopathologic Evaluation of Autologous Blood Injection to the Temporomandibular Joint. J Craniofac Surg. 2011;22:2202-4.
  3. Nitzan DW. Temporomandibular joint ‘open lock’ versus condylar dislocation. Signs and symptoms, imaging, treatment and pathogenesis. J Oral Maxillofac Surg. 2002;60:506-10.
  4. Undt G, Kermer C, Rasse M. Treatment of recurrent mandibular dislocation, Part II: Eminectomy. Int J Oral Maxillofac Surg. 1997;26:98.
  5. Oztan HY, Ulusal BG, Turegun M, Deveci M. Titanium screw implantation to the articular eminence for the treatment of chronic recurrent dislocation of the temporomandibular joint. Int J Oral Maxillofac Surg. 2005;34:921-3.
  6. Schiffman EL, Look JO, Hodges JS, Swift JQ, Decker KL, Hathaway KM, et al. Randomized effectiveness study of four treatment strategies for TMJ closed lock. J Dent Res. 2007;86:58-63.
  7. Babada M, Sahin M, Görgün S. Pre and posttreatment analysis of clinical symptoms of patients with temporomandibular disorders. Quintessence Int. 2004;35:811-4.
  8. MacFarlane WI. Recurrent dislocation of themandible: treatment of seven cases by a simple surgical method. Br J Oral Surg. 1977;14:227-9.
  9. Puelacher WC, Waldhart E. Miniplate eminoplasty: a new surgical treatment for TMJ dislocation. J Craniomaxillofac Surg. 1993;21:176-8.
  10. Gould JF. Shortening of the temporalis tendon for hypermobility of the temporomandibular joint. J Oral Maxillofac Surg. 1978;36:781-3.
  11. Miller GA, Murphy EJ. External pterygoid myotomy for recurrent mandibular dislocation. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol. 1976;42:705-16.
  12. James P. The surgical treatment of mandibular joint disorder. Ann Roy Coll Surg. 1971;49:495-505.
  13. Aquilina P, Vickers R, McKellar G. Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A. Br J Oral Maxillofac Surg. 2004;42:272-3.
  14. Martinez-Perez D, Garcia Ruiz-Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases. J Oral Maxillofac Surg 2004;62:244-6.
  15. Matsushita K, Abe T, Fujiwara T. OK-432 (Picibanil) sclerotherapy for recurrent dislocation of the temporomandibular joint in elderly edentulous patients. Case reports. Br J Oral Maxillofac Surg. 2007;45:511-3.
  16. Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011;69:2962-70.
  17. Kumar AV, Jaishankar HP, Kavitha AP, Naik PR. Prolotherapy: A new hope for TMJ pain. Indian J Pain. 2013;27:119-165.
  18. Emad T. Daif, Autologous blood injection as a new treatment modality for chronic recurrent temporomandibular joint dislocation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:31-6.
  19. Pradhan L, Rahman QB. Effectiveness of Sclerotherapy with Ethanol Amine Oleate in Benign Oral and Perioral Vascular Lesions. BSMMU J. 2011;4:110-5.
  20. Kiripolsky MG. More on Ethanolamine Oleate as a vascular sclerosant. Dermatol Surg. 2010;36:1153-4.
  21. Hong SK, Lee HJ, Seo JK, Lee D, Hwang SW, Sung HS. Reactive Vascular Lesions Treated Using Ethanolamine Oleate Sclerotherapy. Dermatol Surg. 2010;36:1148-52.
  22. Da Silva WB, Ribeiro AL, de Menezes SA, de Jesus Viana Pinheiro J, de Melo Alves-Junior S. Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults. Oral Maxillofac Surg. 2014;18:431-7.
  23. Kotz S, Balakrishnan N, Read CB, Vidakovic B. Encyclopedia of statistical sciences. 2nd ed. Hoboken, N.J.: Wiley-Interscience; 2006.
  24. Kirkpatrick LA, Feeney BC. A simple guide to IBM SPSS statistics for version 20.0. Student ed. Belmont, Calif.: Wadsworth, Cengage Learning; 2013.
  25. Jensen MP, Chen C, Brugger AM. Interpretation of Visual Analog Scale Ratings &change scores: A Reanalysis of two clinical trials of postoperative pain. J Pain. 2003;4:407-14.
  26. Goldman MP. A comparison of sclerosing agents: clinical & histologic effects of intravascular sodium morrhuate, ethanolamine oleate, hypertonic saline(11.7%),and sclerodcx in the dorsal rabbit ear vein. J Dermatol Surg Oncol. 1991;17:354-62.
  27. Ahmed WS. Efficacy of Ethanolamine Oleate Sclerotherapy in Treatment of Peripheral Giant Cell Granuloma. Oral maxillofacial Surg J 2016;74:2200-6.
  28. Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations; percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002;13:475–82.
  29. Das BK, Hoque S. Treatment of Venous Malformations with Ethanolamine Oleate. Asian J Surg. 2008;31:220-4.
  30. Yamamoto K, Sakaguchi H, Anai H, Tanaka T, Morimoto K, Kichikawa K, et al. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience. Cardiovasc Intervent Radiol 2005;28:751-5.
  31. Hedberg SE, Fowler DL, Ryan LR. Injection sclerotherapy of esophageal varices using ethanolamine oleate: a pilot study. Am J Surg 1982;143:426–31.
  32. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003;162:943-51.
  33. Schultz S. Evaluation of periarticular autotransfusion for therapy of recurrent dislocations of the temporomandibular joint. Dtsch Stomatol 1973;23:94-8. 
  34. Jacobi-Hermanns E, Tetsch P. Pericapsular autologous blood injection as therapy for habitualtemporomandibular joint luxation. Dtsch Zahnarztl Z 1981;36:187-90.
  35. Vasconcelos BC, Porto GG, Lima FT. Treatment of chronic mandibular dislocations using miniplatesfollow-up of 8 cases and literature review. Int J Oral Maxillofac Surg 2009;38:933-6.
  36. Anjum S, Faisal M, Nadeem M, Warraich RA. Outcomes of autogenous blood injection in the treatment ofrecurrent dislocation of temporomandibular joint (tmj). Pak Oral Dental J 2013;133:1-16.
  37. Triantafillidou K, Venetis G, MarkosA.Short-term results of autologous blood injection for treatment of habitual TMJ luxation. J Craniofac Surg 2012;23:689-92.
  38. Bayoumi AM, Al-Sebaei MO, Mohamed KM, Al-Yamani AO, Makrami AM. Arthrocentesis followed by intraarticular autologous blood injection for the treatment of recurrent temporomandibular joint dislocation. Int J Oral Maxillofac Surg. 2014;43:1224-8.
  39. Matsumotoa A, Matsumotoa K, Kakimotob N, Yuraaa Y. Arthroscopic findings after autologous blood injection in the treatment of recurrent temporomandibular joint dislocation. J Oral Maxillofac Surg Med Pathol 2015;27:225-7.
Alexandria Dental Journal
Volume 44, Issue 2
August 2019
Pages 101-107

Files

Share

How to cite

Statistics